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Objective: Chronic rhinosinusitis (CRS) is a variable multifactorial disease. It can be divided into forms with nasal pol-
yps (CRSwNP) and without (CRSsNP). Sinus and/or nasal polypectomy surgery are considered if maximal conservative treat-
ment is insufficient. The predictive factors of the need of revision surgery comprise mostly the CRSwNP phenotype and are
not fully understood.
Study Design: The aim of this follow-up study was to evaluate the factors associated with the revision surgery rate in
CRS patients with variable extent of disease.
Methods: Data of CRS patients (N5 178) undergoing sinus surgery and/or nasal polypectomy in 2001 to 2010 were
used. Patient characteristics and follow-up data were collected from patient records and questionnaires. Associations were
analyzed by Fisher’s exact, Mann Whitney U, and the Kaplan-Meier method with log-rank test. Unadjusted Cox’s proportional
hazard models were used for 12 variables and were fitted for the need for revision sinus surgery and/or nasal polypectomy
during follow-up of in average 9 years.
Results: The proportion of CRS patients who had undergone revision in 5 years was 9.6%. After adjustment, the follow-
ing factors associated significantly with the need for recurrent CRS surgery: allergic rhinitis, corticosteroid treatment, previ-
ous surgery of CRS, and recurrent NP.
Conclusion: Increased risk of progressive CRS phenotypes with the need for revision surgery would putatively be recog-
nized by relatively simple clinical questions. Further studies with increased sample size are needed to evaluate whether these
predictive factors would be relevant for developing better detection and management of progressive CRS.
Key Words: Antrochoanal polyp, aspirin-exacerbated respiratory disease, aspirin intolerance, inflammation, nasal polyp,
sinusitis, sinus surgery, recurrence, revision surgery.
Level of Evidence: 2b.
INTRODUCTION
Chronic rhinosinusitis (CRS) is a heterogeneous
group of inflammatory diseases of the nose and para-
nasal sinuses lasting for at least 12 weeks1; it is one of
the most common chronic adult health problems in the
Western world. A European study estimated the preva-
lence of chronic rhinosinusitis (CRS) at 11%, although a
prevalence of 6% to 7% has been observed in studies
with physician-led diagnosis of CRS.2–5 Chronic rhinosi-
nusitis has a severe impact on quality of life that is com-
parable with other chronic diseases such as asthma,
chronic obstructive pulmonary disease, and diabetes.1
The economic burden caused by CRS is significant and
relates largely to loss of productivity, increased doctor’s
appointments, and medical expenses. In United States,
the CRS-related healthcare costs are estimated to be
$6.9 to $9.9 billion dollars (USD) per year.6
The predisposing factors of CRS include genetic fac-
tors, anatomic abnormalities, airborne irritants/allergens/
microbes, and host immunity.7 Chronic rhinosinusitis
with nasal polyps (CRSwNP) and without (CRSsNP) are
considered to be phenotypes of CRS with possibly differ-
ent etiologies and pathomechanisms.1 However, they may
also be interpreted as different degrees of inflammation.1
CRSwNP affects between 1% and 4% of the general popu-
lation.1 Aspirin-exacerbated respiratory disease (AERD)
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has been reported in 8% to 26% of patients with
CRSwNP8; it is characterized by severe eosinophilic
hyperplastic inflammation of all sinuses and nasal pas-
sages, as well as of the lower airways.9
Endoscopic sinus surgery (ESS) has been the most
common type of surgery for rhinosinusitis for those with
failed maximal medical treatments.1 The variation in
using operative management in CRS might reflect a num-
ber of factors, including both underutilization and overu-
tilization of surgery, a lack of guidelines, and a lack of
evidence in well-constructed randomized controlled trials
(RCTs) .2 The Cochrane collaboration stated in 2006 that
ESS offers no additional benefit in relieving symptoms of
CRS compared to medical treatment.10 At that time, only
six randomized controlled trials were available. Although
level 1 evidence is lacking, recent studies evaluating the
symptomatic and economic benefits of surgical interven-
tion in CRS favor surgical intervention over ongoing med-
ical therapy.2,11,12 Studies also suggest that patients with
prolonged and chronic disease might benefit more from
surgery than continued medical therapy.6
Endoscopic sinus surgery usually has high initial
success rate.1 Published success rates for ESS range
from 76% to 98%.13 Common failure factors associated
with ESS include inappropriate surgical technique, poor
operative field or visualization, and inadequate postoper-
ative care.13 Revision ESS is likely to pose more surgical
risks than primary ESS because major complication
rates approximate 1%.14,15 Revision rates range from 3%
to 20%, depending mostly on the population and follow-
up time.14,15 According to a large prospective cohort
study, approximately 20% of patients responded unsatis-
factorily to surgery and required revision during the 5-
year follow-up.15 In this study, 20.6% of the patients
with polyps had revision surgery in the previous 5 years
compared to 15.5% of the patients with CRS alone.15
A few patients have progressive and recurrent forms
of CRS, which is challenging for patients and clinicians.16
Previous studies have mostly been performed in CRSwNP
phenotype and have shown that the following factors
associate with the frequent revisions of CRS: male gen-
der, young adults, smoking, occupational exposure, radio-
logical inflammatory findings in frontal sinus(es),
presence of nasal polyps, asthma, and AERD.16–22 There
is a need to evaluate factors associated with the revision
rate in several types of CRS. The purpose of this study is
to identify the clinical factors that influence the number
and time to revision sinus surgery and/or nasal polypec-
tomy in heterogeneous group of CRS patients.
MATERIALS AND METHODS
Patients
This study was performed at the Departments of Otorhi-
nolaryngology, Tampere University Hospital, P€aij€at-H€ame Cen-
tral Hospital, Mikkeli Central Hospital, Tampere City Hospital,
and Haartman Institute, University of Helsinki, Finland. The
study protocol was approved by the Ethical Committee of Pir-
kanmaa Hospital District and the Administration of the Hospi-
tal. Written informed consent was not required for the
retrospective study populations (II–III) and for the collection of
follow-up data from patient records of study I population. The
study population was composed of different phenotypes of CRS
patients who had undergone to variable extent sinus surgery
and/or polypectomy in 2001 to 2010 (N5 205). The follow-up
data was available from the hospital’s patient records or ques-
tionnaires from a total of 178 (87%) CRS patients. The CRS
patients were from three preexisting studies.23–26 The first study
data was collected from an initial study, which was a prospective
follow-up study that included two sets of patients who underwent
maxillary sinus surgery between 2001 to 2002. Of those, 32 CRS
patients (16 previously operated) underwent maxillary sinus
surgery6 ethmoidectomy6nasal polypectomy, and 25 non-
previously operated CRSsNP patients underwent simple
uncinectomy-only on one side and simple uncinectomy with mid-
dle meatal antrostomy on the other side.25,26 Written informed
consent from the initial first prospective study patients was
obtained. The second study was a retrospective follow-up study
of 63 CRSwNP patients (16 previously operated) who underwent
nasal polypectomy6 sinus surgery between 2005 to 2006.23 Eight
of these CRSwNP patients had antrochoanal polyps (ACP) and
were a part of a random sample of our hospital’s nasal polyp
cases. The third study was a retrospective follow-up study of 58
nonoperated CRSsNP patients. Of these, 28 had undergone sim-
ple maxillary balloon sinuplasty and 30 simple middle-meatal
antrostomy between 2008 to 2010.24 Diagnosis of CRSsNP,
CRSwNP, or ACP was based on the criteria of the European posi-
tion paper on rhinosinusitis and nasal polyps (EPOS) for symp-
toms, endoscopic, and sinus computed tomography findings were
based on the patient records.1 The exclusion criteria in all
cohorts were cystic fibrosis and primary ciliary dyskinesia.
Data Collection
Patient records were abstracted for time until revision sur-
gery and variables that could potentially influence the need for
revision surgery: age; gender; asthma diagnosis; AERD; AR;
current/recurrent NP; previous sinus surgery and/or nasal pol-
ypectomy operation(s); smoking history; occupational exposure;
need for regular intranasal corticosteroids; preoperatively
administered peroral corticosteroid course; and the initial study
operation (only polypectomy, ESS6polypectomy, only maxillary
mini-invasive ESS e.g. uncinectomy-only on one side, only max-
illary balloon sinuplasty). The number of revision sinus opera-
tions and/or revision nasal polypectomies during follow-up were
calculated. Time until the first revision sinus surgery and/or
nasal polypectomy was defined a priori as the time between the
initial study operation and the first revision sinus surgery and/
or nasal polypectomy during follow-up.
Diagnosis of allergic rhinitis was based on subject-
reported doctor-diagnosed AR and/or skin prick test positivity
and report of typical symptoms following exposure to allergen
to which sensitized. Diagnosis of asthma was based on a patient
record of clinical features and diagnostic pulmonary function
tests, corresponding with the Global Initiative for Asthma diag-
nostic criteria.27 Diagnosis of AERD was made on the basis of a
history of wheezing or asthma attacks precipitated by nonster-
oidal antiinflammatory drugs. The data of the presence of occu-
pational exposure was available only in 107 (60.1%) patients. Of
these, 34 (19.1%) had occupational airway exposure. The main
substances causing job exposure were: bioaerosols, agricultural
organic particles, wood/textile dust, mites, molds, flour, and
reactive chemicals/metalwork. None of the subjects had under-
gone aspirin desensitization, allergen immunotherapy, or anti
IgE therapy prior to operation or during follow-up.
The information of other general diseases than CRS/AR/
asthma was available from 173 patients (97.2%). Of these, there
Laryngoscope Investigative Otolaryngology 1: August 2016 Koskinen et al.: Factors Affecting Revision Rate of CRS
97
were no reported other diseases in 118 (68.2%) patients, and 55
(41.8%) of patients reported suffering from diseases (other than
CRS/AR/asthma) with regular need of medications. Twenty-one
(12.1%) patients were reported as having one additional disease,
13 (7.5%) as having two diseases, and 21 (22.2%) as having three
or more diseases. The most frequent diseases were (number of
patients): heart and vascular diseases (40), nonasthma respira-
tory diseases (23), obesity/hyperlipidemia/diabetes (15), thyroid
diseases (5), musculoskeletal diseases (5), and psychiatric dis-
eases (5).
Data Analysis
Statistical analysis was carried out by the IBM SPSS Sta-
tistics 23 Statistical Software Package (SPSS Inc., Chicago, IL).
Descriptive statistics for subject characteristics were presented
in the CRS groups with/without revision surgery in 5 years.
Fisher’s exact test (2-tailed) was used to compare patient charac-
teristics. The Kruskal-Wallis test and Mann Whitney U test was
used to study the comparison of the total Lund-Mackay scores of
sinus computed tomography (CT) scans or magnetic resonance
imaging (MRI). The time periods between the initial study opera-
tion and second surgeries were analyzed by the Kaplan-Meier
method and compared with the log-rank test. Survival was calcu-
lated from the date of the initial study operation to first follow-
up revision sinus surgery and/or nasal polypectomy/death/end of
March 2015, whichever came first. Univariate and multivariable
Cox’s proportional hazard models for interval to second surgery
were constructed with the following predictor variables: age; gen-
der; asthma diagnosis; AERD; AR; current/recurrent NP; previ-
ous sinus surgery and/or nasal polypectomy operation(s);
smoking history; need for regular intranasal corticosteroids; pre-
operatively administered peroral corticosteroid course; and the
initial study operation (only polypectomy, ESS6polypectomy,
only maxillary mini-invasive ESS e.g. uncinectomy-only on one
side, only maxillary balloon sinuplasty). The variables for the
multivariable Cox’s proportional hazard model were chosen from
those that were statistically significant variables in univariate
Cox’s proportional hazard models. Statistical significance was set
at a P level of less than 0.05, and all tests were 2-tailed.
RESULTS
Patient Characteristics
The characteristics are shown in Table I. We com-
pared the factors between the groups with/without revi-
sion surgery in 5 years. These patient groups were
significantly different in terms of the presence of AR,
need for regular intranasal corticosteroid therapy, and
previous sinus surgery and/or nasal polypectomy (Table
I). Preoperative sinus CT scans only were available in 89
(50%) of the patients. Of these, the mean (minimum–
maximum) Lund-Mackay total score of CT scans or MRI
was 7.9 (0–22) in the group that did not undergo revi-
sion surgery in 5 years, and was 8.7 (3–17) in the group
that underwent revision surgery in 5 years. This differ-
ence was not statistically significant (P5 0.74 by Mann
Whitney U test). Sinus surgery and/or nasal polypec-
tomy prior to the initial study operation had been per-
formed in 32 (18.0%) patients. Of these, 26 (26.8%) were
in the CRSwNP group and six (7.5%) were in the
CRSsNP group. The difference was statistically signifi-
cant (P50.001, Fisher’s exact test).
Revision Operations During 5-Year Follow-Up
There were 17 (9.6%) CRS patients who had under-
gone at least one revision CRS operation in 5 years
(Table I). During the 5-year follow-up, the factors associ-
ating significantly with the need for revision sinus sur-
gery and/or nasal polypectomy were AR, AERD, the
need of regular intranasal corticosteroid treatment, pre-
operative peroral corticosteroid, previous sinus surgery
and/or nasal polypectomy, and ethmoidectomy performed
as part of current surgery (P< 0.02) (Table I) (Fig. 1). In
contrast, age, gender, smoking, method of the current
operation, recurrent NP, and the presence of asthma or
NP (current6previous) did not associate with the revi-
sion during follow-up (P0.05) (Table I). Occupational
exposure, the presence of general diseases, or the num-
ber of general diseases (other than CRS/AR/asthma)
were not associated with the revision during follow-up
(P> 0.05) .
Revision Operations During Total Follow-up
Time
The mean (minimum–maximum) total follow-up of
all subjects was 8.7 (1–14) years. There were eight
deaths (6 CRSwNP, 2 CRSsNP) during follow-up time.
None of the deaths were caused by CRS or surgery of
CRS. None had undergone revision of CRS during
follow-up prior to death. The total follow-up of the
patients who were alive until 2015 was 8.9 (4–14) years.
During the total follow-up, 17 (9.6%) of the CRS patients
had undergone one revision operation; three (1.7%)
patients had undergone two revisions; and three (1.7%)
patients had undergone three revisions. The revision
operations were ethmoidectomy (N5 14), nasal polypec-
tomy (N57), middle meatal antrostomy (N5 12), and
frontal recess/sinus surgery (N5 3). Moreover, septo-
plasty was performed to four patients who also under-
went CRS surgery. The revision operation was more
extensive than the previous one in 20 (87.0%) of the
cases. The number of revision operations during follow-
up was significantly higher in patients with reported
AR, AERD, regular need for intranasal corticosteroid, or
with preoperative peroral corticosteroid treatment
(P< 0.004) (Fig. 1). In contrast, the following factors did
not associate with the revision during follow-up: age;
gender; smoking; occupational exposure; method of the
current operation; and the presence of asthma or NP,
the presence of general diseases (other than CRS/AR/
asthma), or the number of general diseases (P> 0.05,
Fisher’s exact test).
Kaplan Meier Survival Analyses
In the survival analyses, the mean (minimum–max-
imum) follow-up time was 7.9 (1–14) years until the first
revision surgery/death/end of March 2015, whichever
came first. The factors associating significantly with the
need for revision sinus surgery and/or nasal polypectomy
were AR, AERD, recurrent NP, the need for regular
intranasal corticosteroid treatment, preoperative peroral
corticosteroid, and previous sinus surgery and/or nasal
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TABLE I.
Characteristics of CRS Patients With/Without Status of Revision Sinus Surgery and/or Polypectomy 5 Years After Current Operation.
Revision Sinus Surgery and/or Polypectomy in
5 Years
No (N5 161) Yes (N517)
N % N % P Value
Gender
Male 79 49.1 7 41.2 .62
Female 82 50.9 10 58.8
Age
< 40 years 46 28.6 7 41.2 .28
 40 years 115 71.4 10 58.8
Allergic rhinitis
No 101 62.7 4 23.5 .002
Yes 56 34.8 13 76.5
Unknown 4 2.5 0 0
Asthma
No 105 65.2 10 58.8 .60
Yes 55 34.2 7 41.2
Unknown 1 0.6 0 0
AERD
No 144 89.4 13 76.5 .12
Yes 17 10.6 4 23.5
Current nasal polyps
No 77 47.8 4 23.5 .11
ACP 7 4.3 1 4.9
Conventional NP 77 47.8 12 70.6
Recurrent nasal polyps
No 149 92.5 13 76.5 .05
Yes 12 7.5 4 23.5
Previous and/or current nasal polyps
No or ACP 84 52.2 5 29.4 .06
Yes 77 47.8 12 70.6
Smokers
No 124 77.0 15 88.2 .53
Yes 34 21.1 2 11.8
Unknown 3 1.9 0 0
Need for regular intranasal corticosteroid
No 93 57.8 2 11.8 <.001
Yes 59 36.6 15 88.2
Unknown 9 5.6 0 0
Preoperative peroral corticosteroid
No 148 91.9 12 70.6 .016
Yes 8 5.0 4 23.5
Unknown 5 3.1 1 5.9
Previous sinus surgery and/or polypectomy
No 137 85.1 8 47.1 .001
Yes 23 14.3 9 52.9
Unknown 1 0.6 0 0
Current sinonasal operation
Only polypectomy 32 19.9 0 0 .13
ESS6polypectomy 82 50.9 11 64.7
Only maxill. mini-invasive ESS1 23 14.3 2 11.8
Only maxill. balloon sinuplasty 24 14.9 4 23.5
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polypectomy (P< 0.02) (Fig. 2). However, age, gender,
smoking, method of the current operation, or the pres-
ence of asthma or NP did not associate with the revision
during follow-up (P>0.05) (Table II). The presence of
occupational exposure or the presence of other general
diseases than CRS/AR/asthma did not associate with the
need for revision surgery (P5 0.90, P5 0.27, respec-
tively, by the log-rank test).
Cox Regression Analyses
Cox’s proportional hazards analysis was conducted
to determine which factors were predictive of surgery
recurrence. Of the possible predictive factors, AR,
AERD, recurrent NP, the need of regular intranasal cor-
ticosteroid treatment, preoperative peroral corticoste-
roid, previous sinus surgery and/or polypectomy, and
ethmoidectomy performed as a part of current surgery
were significantly predictive for revision surgery
(P< 0.03) (Table II). No other covariate was significantly
predictive surgery recurrence. Antrochoanal polyps did
not affect the result (Table II). Each of the previously
mentioned seven significant predictive variables was
entered into the adjusted Cox’s proportional hazard
model. In this multivariable analysis, AR, peroral or
intranasal corticosteroid treatment, and recurrent NP
were significantly predictive for surgery recurrence
(Table II). Thus AR, corticosteroid, treatment and recur-
rent NP seems to predict independently surgery
recurrence.
DISCUSSION
The clinically most useful predictive factors would
be specific, sensitive, easy, and usable across nonselected
CRS populations. Thus, this study was implemented to
evaluate simple factors associating the revision rate of
heterogeneous CRS population with both CRSsNP and
CRSwNP phenotypes and with inclusion of also less
severe cases. The most significant finding was that the
factors associating significantly with the recurrence of
surgery were AR, recurrent NP, peroral or intranasal
corticosteroid treatment, and previous surgery. These
factors associated with the number of revision opera-
tions, and they also independently predicted the need
for revision surgery in the survival analyses.
To the knowledge of the authors, there exist only
two previous studies on recurrent sinus surgery using
survival analysis technique. Mendelsohn et al. per-
formed a survival analysis of a cohort of 549 CRSwNP
patients who underwent ESS over a 10-year period.16
Revision surgery occurred at a high rate, especially in
patients with asthma, AERD, or frontal sinus disease. In
our study population of both CRSsNP and CRSwNP
patients, we were able to demonstrated association
between recurrent NP and previous operation(s); how-
ever, we were not able to demonstrate independent asso-
ciation of asthma or AERD with recurrent surgery. This
might reflect the differences in our study populations.
Wu et al. reviewed records of 299 CRSwNP patients who
underwent two or more surgeries from 1987 through
2011.17 They found that revision surgery and regrowth
of nasal polyps appears to be affected by smoking and
operative technique but not by other factors such as
asthma or advanced CT stage. The performance of mid-
dle turbinate resection in this study population was
found to significantly delay the time until revision sur-
gery; however, the beneficial effect of turbinectomy
appeared to dissipate by 8 years. In our study, smoking
did not predict surgery recurrence; therefore, further
studies on this are required.
Wu et al. found that the mean number of surgeries
performed per CRSwNP patient was 2.3, and the mean
time between sinus surgeries was 4.9 years.17 Con-
trasted to this, in our study the median number of revi-
sion surgeries during follow-up was 0 in both CRSsNP
and CRSwNP groups. However, we found that the
higher number of revision surgeries associated with the
history of AR, AERD, recurrent NP, previous sinus sur-
gery and/or nasal polypectomy, and the regular need for
intranasal corticosteroid and preoperative corticosteroid,
which reflects the previous findings.17
More studies exist on revision rate, especially in
CRSwNP patients without using survival method. A
study showed that male patients and younger adult
patients were found to have higher revision rates13;
however, we were not able to demonstrate this. In addi-
tion, Chang et al. found that patients with asthma or
allergic rhinitis had higher revision rates compared
with those patients without these comorbidities.13 This
is in part in line with our findings that allergic rhinitis
TABLE I.
(Continued)
Revision Sinus Surgery and/or Polypectomy in
5 Years
No (N5 161) Yes (N517)
N % N % P Value
Ethmoidectomy performed as a part of current surgery
No 109 67.7 6 35.3 .010
Yes 52 32.3 11 64.7
P values by Fishers exact test.
1Uncinectomy-only in one side and uncinectomy1 antrostomy on the other side of each patient.
AERD5 aspirin-exacerbated respiratory disease; ACP5 antrochoanal polyp; ESS5 endoscopic sinus surgery; maxill.5maxillary (sinus); NP5 nasal
polyps.
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independently predicted recurrent surgery. The etiology
between allergy and rhinosinusitis is multifactorial,
and a clear consensus of their relation does not exist at
present. However, previous studies suggest atopy being
a predisposing factor for CRS. It has been postulated
that patients with allergic rhinitis have edematous
nasal mucosa, impaired cilia function, and overproduc-
tion of secretions, which lead to blockage at the site of
ostiomeatal complex, impaired drainage and ventila-
tion, and again to sinus problems.28 Recently, Wilson
Fig. 1. Comparison of number of revision sinus operations and/or revision nasal polypectomies in different CRS patient groups during
follow-up of in average 9 years. CRS patient group (A) with/without the presence of allergic rhinitis. (B) The presence of aspirin-
exacerbated respiratory disease. (C) The regular use of intranasal corticosteroid. (D) Preoperative peroral corticosteroid course. (E) Recur-
rent nasal polyps. (F) Previous sinus surgery and/or nasal polypectomy.
P values by Fishers exact test.
AERD5 aspirin-exacerbated respiratory disease; CRS5 chronic rhinosinusitis.
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et al. reviewed 24 articles examining the relationship of
allergy and CRSsNP and/or CRSwNP.29 According to their
analysis, the role of allergy in CRSwNP and CRSsNP con-
tinues to be controversial, with the level of evidence
poor.29 We recently demonstrated that sensitization to
over five common airborne allergens and to several aller-
gen groups associate strongly with adult asthma.30 It
could be speculated that multiple allergen sensitization
might be associated with progressing CRS, whereas sim-
ple pollen allergic rhinitis does not associate with severe
CRS. Although not yet proven, this could in part explain
controversial findings of the association between
CRS(wNP) and atopy. Thus, future studies on sensitiza-
tion patterns and the association with CRS progression
would be important to understand the mechanisms behind
CRS development, prevention of CRS, and its progression.
The presence of general diseases did not associate with
recurrent surgery. To the knowledge of the authors, there
Fig. 2. Predictive effect of different fac-
tors to the time until revision sinus sur-
gery and/or nasal polypectomy was
performed according to the Kaplan-
Meier method. (A) Predictive effect of a
patient history of doctor-diagnosed aller-
gic rhinitis in all CRS patients (N5174).
(B) Predictive effect of a patient history
of doctor-diagnosed AERD in all CRS
patients (N5 178). (C) Predictive effect
patient-reported regular need of intra-
nasal corticosteroid treatment in all CRS
patients (N5169). (D) Predictive effect
of preoperative peroral corticosteroid
treatment in all CRS patients (N5172).
(E) Predictive effect of previous sinus
surgery and/or nasal polypectyomy in all
CRS patients (N5177). (F) Predictive
effect of recurrent nasal polyps in all
CRS patients (N5 178). (G) Predictive
effect of maxillary sinus operation tech-
nique in all the CRS patients who under-
went current maxillary sinus surgery
(N5 146). (H) Predictive effect of maxil-
lary sinus operation technique in the
subgroup of CRSsNP patients who
underwent current maxillary sinus sur-
gery (N5 81).
P values by log-rank test.
AERD5 aspirin-exacerbated respiratory
disease; CRS5 chronic rhinosinusitis;
CRSsNP5 chronic rhinosinusitis without
nasal polyps; ESS5 endoscopic sinus
surgery; mini-invasive ESS5uncinec-
tomy-only in one side and uncinecto-
my1 antrostomy on the other side of
each patient.
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are no reports of the effect of general diseases on the recur-
rence of CRS surgery. The effect of occupational exposure
has previously been studied. Hox et al. performed a ques-
tionnaire study with 890 patients who had undergone one
or more ESS, and with 182 controls.18 After adjustments,
the authors detected that the prevalence of occupational
exposures associated significantly with the number of ESS
procedures. The authors concluded that exposure at work
appears to be a risk factor for the occurrence of CRS and
for its recurrence or persistence, as evidenced by the need
for revision surgery.18 In this current study, we were not
able to comprehensively study the effect of occupational
exposure to revision rate because the occupational data
was available from only about 40% of the patients.
Performing ethmoidectomy as a part of current surgery
was associated with recurrent CRS surgery. After adjust-
ment, ethmoidectomy did not associate with revision surgery.
This might be due to the fact that the majority of those who
TABLE II.
Unadjusted and Adjusted Cox’s Proportional Hazard Models for Variables Analyzed Fitted for Need for Revision Sinus Surgery and/or Nasal
Polypectomy During Follow-up of Average 9 Years.
Revision Sinus Surgery and/or Polypectomy
Univariate Multivariable
Events
(23) HR 95% CI P Value HR 95% CI P Value
Gender
Male 9 1 Not entered
Female 14 1.54 0.67–3.56 .31
Age
< 40 years 8 1 Not entered
 40 years 15 0.77 0.33–1.82 .56
Allergic rhinitis
No 8 1 1
Yes 15 2.86 1.21–6.76 .017 3.97 1.34–11.73 .013
Asthma
No 12 1 Not entered
Yes 11 1.71 0.76–3.88 .20
AERD
No 16 1 1
Yes 7 3.37 1.38–8.23 .008 0.34 0.076–1.48 .15
Previous and/or current nasal polyps
No or ACP1 7 1 Not entered
Yes 16 2.31 0.94–5.68 .07
Recurrent nasal polyps
No 16 1 1
Yes 7 5.08 2.07–12.45 < .001 5.77 1.37–24.3 .017
Smokers
No 21 1 Not entered
Yes 2 0.34 0.08–1.45 .15
Need for regular intranasal corticosteroid
No 4 1 1
Yes 19 6.63 2.26–19.49 .001 4.64 1.47–14.68 .009
Preoperative peroral corticosteroid
No 16 1 1
Yes 6 5.13 2.00–13.15 .001 9.27 1.89–45.40 .006
Previous sinus surgery and/or nasal polypectomy
No 11 1 1
Yes 12 5.06 2.23–11.49 <.001 2.50 0.60–10.36 .21
Ethmoidectomy performed as a part of current surgery
No 9 1 1
Yes 14 2.70 1.17–6.27 .021 0.48 0.13–1.80 .28
The six variables that entered the adjusted Cox’s proportional hazard were chosen from those that were statistically significant variables in unadjusted
Cox’s proportional hazard models.
1When removing ACP from the analysis, the result remained similar.
ACP5 antrochoanal polyp; AERD5 aspirin-exacerbated respiratory disease; CI5 confidential interval; HR5 hazard ratio.
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underwent primary ethmoidectomy were NP patients, and
the status of recurrent NP had stronger independent associa-
tion with the need for revision surgery than ethmoidectomy.
A study suggests that primary ESS failure is most
often associated with re-obstruction in the area of the ostio-
meatal complex.13 We demonstrated here that a minimally
invasive operation slightly and insignificantly increased
the revision rate in the CRSsNP subgroup; however, mini-
mally invasive approaches (e.g., balloon sinuplasty and
uncinectomy-only) did not have an effect on the revision
rate when observing all CRS patients. In terms of the need
for recurrent CRS surgery, a minimally invasive technique
might be sufficient; however, our previous controlled study
demonstrates that radiological recovery was slightly infe-
rior after uncinectomy-only technique compared to antros-
tomy.25 Moreover, it is highly important to further follow
up the recurrence of surgeries in patients with balloon sin-
uplasty because the balloon sinuplasty procedures were
started in Finland in 2008.
We found that previous surgery was performed in
about 26% of CRSwNP patients and to a significantly
lower extent in CRSsNP patients (7.5%). In accordance
with our findings, a study observed a revision rate in
CRS 4,484 patients who had undergone ESS.13 The
study group found that the number of patients who
underwent revision ESS was 528 (11.78%). Another
study group investigated 1,249 CRS patients and 221
controls in United Kingdom by means of a self-
administered questionnaire.2 A total of 396 (57%)
patients with CRSwNPs/allergic fungal rhinosinusitis
(AFRS) reported having undergone previous endoscopic
nasal polypectomy; of those, 182 of the 396 (46%)
reported having received more than one operation.2 In
comparison, surgical rates in patients with CRSsNPs
were significantly lower: 13% of cases specifically
reported ESS; and of those, only 30% reported multiple
procedures.2 The reasons of higher percentage of previ-
ous surgery in the study of Philpott et al. compared to
ours might be related to differences in the populations,
study design, and management of CRS patients.2
We found that only about one-tenth of CRS patients
required re-operation in 5 years. A study showed that revi-
sion surgery rates at 5 years were 10%, 25%, and 37% for
control patients, patients with asthma, and patients with
AERD, respectively.16 Prior studies have reported recur-
rence rates in shorter mean follow-up periods (less than 5
years) of between 21% and 66% for CRSwNP, but most did
not subdivide among patient groupings or did not comment
on revision surgery rates.16,31–37
Philpott et al. showed the highest rate of revision
surgery to be among those with CRSwNPs and AFRS,
with rates of previous surgery almost twice that of those
without nasal polyps, which is supported by the U.K.
Sinonasal Audit.2 We also demonstrated here a clear
association of CRSwNP phenotype with both increased
prior operation(s), as well as recurrent NP as an inde-
pendent predictor for revision during follow-up. There is
a growing acceptance that patients with and without
polyps have distinct differences. This is reflected in the
current iteration of EPOS, with different treatment algo-
rithms for the two main phenotypes.1,2 In line with this,
we showed that recurrent NP was an independent pre-
dictive factor for recurrence of surgery.
Studies suggest that a crucial factor in the success
or failure of surgical intervention will be patient compli-
ance with ongoing medical management postopera-
tively.2 The authors suggested that this may currently
be counteracted by differing advice from primary and
secondary care practitioners and emphasizes the need
for greater awareness of guidelines; however, there is
also a need for further clinical trials in terms of medical
treatment to underpin this.2 We found that regular
intranasal corticosteroids did not delay recurrence of
surgery; in contrast, they associated with increased revi-
sion rate. Regular intranasal corticosteroid treatment,
which most patients reported to continue to use regu-
larly also postoperatively, predicted independently
increased revision rate. Moreover, the need for preopera-
tive peroral corticosteroid course predicted independ-
ently increased revision rate. The need for regular
intranasal and preoperative peroral corticosteroids
would putatively reflect severe CRSwNP and uncon-
trolled CRS (with/without atopy). Together, it seems that
a more severe/uncontrolled CRS phenotype could be
identified. It might be related to recurrent NP and atopy
but might be independent of AERD and asthma. Despite
maximum management, this phenotype might need fre-
quent surgical interventions. The putative reasons for
progression of CRS in these patients might be genetic
and immunological, affecting interactions between host
barrier immunity and environmental irritants/microbes.7
These patients do not fully respond the current treat-
ment with corticosteroids and surgery, and are thus in
high need for advanced management such as biological
treatment and other future therapeutic interventions.
This study did not measure polyp regrowth or other
signs of uncontrolled CRS, which would have reflected
more precisely the progressing CRS. Revision CRS sur-
gery was chosen as the end point because there is a lack
of good objective data of CRS progression. Serial nasal
endoscopy shows nasal polyp regrowth but has limited
correlation with the severity of CRS(sNP)38; and serial
sinus CT scans cannot be performed due to radiation.
Thus, we observed the recurrent surgery as a clearly
defined event, which indirectly reflects to CRS progres-
sion. This study did not distinguish between revision
CRS surgery due to suboptimal surgery and to recur-
rence of CRS. This study also did not measure differen-
ces in postoperative medical treatments that could affect
timing of revision surgery. Our scope was to detect pre-
dictive factors that would associate with recurrent CRS
surgery independent of these factors and despite hetero-
geneity in CRS population.
This study has several limitations. The sample was
heterogeneous and small in size for clinically relevant
conclusions. No CRS cases with cystic fibrosis or with
primary ciliary dyskinesia were available for this study.
A shortcoming is that the diagnosis of AR was not based
on skin-prick test positivity in all patients; and the diag-
nosis of AERD was not based on nonsteroidal anti-
inflammatory drugs challenge test in all patients. There
also might have been limitations in the collection of
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other variables from patient records. The fact that
patients with balloon sinuplasty were followed up for a
significantly shorter time than other patients introduces
the possibility that the increased revision surgery rates
were not yet detected properly in this group. Our analy-
sis of revision surgery may have been influenced by sev-
eral factors unrelated to recurrence of CRS, including
wait times for surgery and patients’ preferences to delay
surgery for personal reasons. Other factors that can also
affect the timing of revision surgery include the patient’s
tolerance of recurrent sinusitis symptoms, the operative
technique used at the time of the initial surgery, and the
surgeon’s opinion concerning when revision surgery is
clinically warranted. Additionally, some patients might
have sought treatment elsewhere and were lost to
follow-up. A strength of our study was our observation
of the heterogeneous CRS population and not only the
CRSwNP phenotype.
CONCLUSION
This study demonstrate that revision surgery occurs
in about 10% of CRS patients despite active therapy.
Progressive chronic inflammatory phenotype would
putatively be recognized by relatively simple questions
concerning atopy, recurrent NP, previous CRS surgeries,
and need for corticosteroid therapy. These patients
should be informed of the significant likelihood of revi-
sion surgery. Further studies with increased number of
patients, populations, and rare cases are mandatory to
evaluate whether these questions and factors would be
relevant for developing better detection and manage-
ment of uncontrolled CRS.
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